A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate.
Kathleen F PirolloManish MogheMiaoyin GuanAntonina S RaitAibing WangSang-Soo KimEsther H ChangJoe B HarfordPublished in: International journal of nanomedicine (2024)
Our data indicate that scL-2PAM is superior to the currently used form of 2-PAM in terms of both mitigating paraoxon toxicity in mice and reactivating acetylcholinesterase in their brains.